A systematic assessment of causes of death after heart failure onset in the community: impact of age at death, time period, and left ventricular systolic dysfunction
about
Clinical Phenotypes in Heart Failure With Preserved Ejection FractionGender and incidence of dementia in the Framingham Heart Study from mid-adult lifeQuality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy.Clinical Risk Stratification for Primary Prevention Implantable Cardioverter DefibrillatorsThe challenge of heart failure discharge from the emergency department.Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction.Lifetime analysis of hospitalizations and survival of patients newly admitted with heart failure.Discriminating clinical features of heart failure with preserved vs. reduced ejection fraction in the community.Heart failure with preserved ejection fraction in African Americans: The ARIC (Atherosclerosis Risk In Communities) studyHeart failure in elderly: progress in clinical evaluation and therapeutic approach.Pathological ventricular remodeling: mechanisms: part 1 of 2Heart Failure in Women--Insights from the Framingham Heart Study.Mortality in heart failure patients.Heart failure with preserved ejection fraction in the elderly: scope of the problem.How do patients with heart failure with preserved ejection fraction die?Use of stem cells in heart failure treatment: where we stand and where we are going.Heart failure with preserved ejection fraction: a heterogenous disorder with multifactorial pathophysiology.Left ventricle diastolic dysfunction and prognosis.Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction.Long-term prognostic impact of left ventricular remodeling after a first myocardial infarction in modern clinical practice.Epidemiology of Left Ventricular Systolic Dysfunction and Heart Failure in the Framingham Study: An Echocardiographic Study Over 3 Decades.Sex differences in outcomes of primary prevention implantable cardioverter defibrillator therapy: combined registry data from eleven European countries.Risk factors for rehospitalization in heart failure with preserved ejection fraction compared with reduced ejection fraction.Characteristics and prognosis of heart failure with improved compared with persistently reduced ejection fraction: A systematic review and meta-analyses.Intravenous delivery of adeno-associated virus 9-encoded IGF-1Ea propeptide improves post-infarct cardiac remodelling.Why and how do elderly patients with heart failure die? Insights from the TIME-CHF study.Clustered Emergency Room Visits Following an Acute Heart Failure Admission: A Population-Based Study.Prediction of sudden death in elderly patients with heart failure.Factors related to outcome in heart failure with a preserved (or normal) left ventricular ejection fraction.
P2860
Q28073079-54405A30-73E9-46B5-98EA-2AC7471B5553Q33882491-9407ACCE-D836-4BAA-9B8C-63B74367170CQ35629873-CD56A3A8-6C8A-4522-A844-8106FF39DA59Q36057430-AE05A8A5-3FB4-4318-A33C-2FD1DBE6D904Q36120865-C6F22BD9-4E96-4018-888C-6D8D002A8446Q36393927-986B9031-13B6-4AB4-8D03-9FD50C710817Q36429019-4A555D82-5AD8-46A3-9032-888F24410144Q36489384-105D80F7-7C32-4A36-945A-CF7E644E79D8Q36833984-79C73F73-803E-41B9-BE71-93EEFA73E2BBQ37001576-B3DD6CF8-876C-4310-9A93-34058CAE1315Q37241166-A421B51D-9584-48DF-AD8E-1F01FBB0FDAAQ37637447-FD97CCAF-DDD2-46F0-9E88-8F6F72C87F9EQ37680497-D52D2AA1-0F0F-4607-A3D0-E4B13541D448Q37912065-8E6F187F-8F84-401B-8F4E-2448A4C7F561Q38101027-982D8D9C-A157-4266-B023-B8627C87BFAEQ38168204-ACA9575A-A4AC-4123-9B0E-C1FED1588FDFQ43090086-DB83702F-5532-4C04-8B8E-0371D3C28D38Q43195218-501A0C02-A309-469A-A61B-A5B1FF27419FQ47102600-48FD2E8B-B16E-4967-B51C-B6085379C31EQ47159025-AABD0746-613C-46F7-BF81-9565663F4834Q47767547-9728159D-271E-4E93-AD40-054B8AC11DFDQ47827598-74A30FC8-573B-4C71-B812-B6623CDEFF2AQ48272339-5506E7E0-E13C-4287-A4DA-D2F0BB654B64Q50127271-98DE68A8-6442-4C28-B219-3175C5335CA9Q50852666-3CD98289-321B-464E-9CD6-B6E2242CEDF1Q51346354-0C4ED402-148E-4C9F-A0D8-ADB39380A317Q52340008-A676B751-502E-458C-9CE4-1FC97B7995FFQ52584402-5C2FBD1E-CC71-402E-9046-3A6FBD860BA4Q53021759-2CBB32E2-7FE2-4ECB-91AF-C00243B636B9
P2860
A systematic assessment of causes of death after heart failure onset in the community: impact of age at death, time period, and left ventricular systolic dysfunction
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
A systematic assessment of cau ...... ntricular systolic dysfunction
@ast
A systematic assessment of cau ...... ntricular systolic dysfunction
@en
type
label
A systematic assessment of cau ...... ntricular systolic dysfunction
@ast
A systematic assessment of cau ...... ntricular systolic dysfunction
@en
prefLabel
A systematic assessment of cau ...... ntricular systolic dysfunction
@ast
A systematic assessment of cau ...... ntricular systolic dysfunction
@en
P2093
P2860
P50
P1476
A systematic assessment of cau ...... ntricular systolic dysfunction
@en
P2093
Daniel Levy
Douglas S Lee
Irene Albano
William B Kannel
P2860
P356
10.1161/CIRCHEARTFAILURE.110.957480
P577
2010-11-11T00:00:00Z